Learn how to design a simplified, cost-effective LVV manufacturing workflow

Tuesday 08:00 PDT / 11:00 EDT / 16:00 BST / 17:00 CEST

Sponsor

Learn how to design a simplified, cost-effective LVV manufacturing workflow

Discover how to design an LVV manufacturing workflow with cost savings of up to 35% compared to a traditional manufacturing process and a reduced production timeline as short as just 7 days, cutting processing time by over 26%.

Attend this webinar for insights into how fixed-bed bioreactors can intensify and streamline LVV manufacturing, delivering up to 10x higher productivity. Data on a novel, resin-free affinity purification approach using thermoresponsive proteins that achieves up to 4-log reduction in impurities with ~30% recovery of functional vector will be presented. This will be alongside a case study showing how combining these two innovations supports a simplified, cost-effective, end-to-end LVV workflow.

Attend this webinar to learn about:

Improving efficiency with a manufacturing workflow tailored to the unique needs of LVV manufacturing
Next generation upstream and downstream approaches to achieve increased yields and recoveries
Decreasing LVV manufacturing cost per batch with a low-cost end-to-end workflow
Increasing impurity removal and product recovery without the need for an affinity resin

Nicole Votaw

Associate Director, R&D at Isolere Bio, Donaldson Life Sciences

Nikki Votaw, PhD, is Associate Director at Isolere Bio, part of Donaldson Life Sciences. She has spent several years advancing the development of next-generation protein reagents to optimize downstream manufacturing for viral vectors. Her work supports a shift in purification strategies that could significantly improve the accessibility of gene therapies worldwide. Nikki is also an author on multiple patents and publications stemming from both academic and industry research.

Thomas Robert

Senior Innovation & Product Manager at Univercells Technologies, Donaldson Life Sciences

Thomas Robert, PhD, is Senior Innovation and Product Manager at Univercells Technologies, part of Donaldson Life Sciences. With a doctorate in medical sciences and a background in biology, Thomas brings deep expertise in bioprocessing and advanced therapies. He leads the development and commercialization of innovative biomanufacturing platforms designed to make cell and gene therapy production more scalable, efficient, and cost-effective.

Shameer Subratty

Director, Product Strategy at Isolere Bio, Donaldson Life Sciences

Shameer Subratty, MEng, is Director of Product Strategy at Isolere Bio, part of Donaldson Life Sciences. He brings over a decade of experience in developing novel purification technologies to improve the efficiency and cost-effectiveness of biotherapeutic manufacturing. His work has helped position emerging membrane technologies for commercial success and acquisition, including the Fibro platform at Puridify. Shameer is also an inventor on multiple patents for membrane chromatography systems.

in 21

Days